Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 1762-1772, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (44)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myers, G. L.
Right arrow Articles by Sampson, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myers, G. L.
Right arrow Articles by Sampson, E. J.
Related Collections
Right arrow Laboratory Management
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2000;46:1762-1772.)
© 2000 American Association for Clinical Chemistry, Inc.

Articles

A Reference Method Laboratory Network for Cholesterol: A Model for Standardization and Improvement of Clinical Laboratory Measurements

Gary L. Myersa,1, Mary M. Kimberly1, Parvin P. Waymack1, S. Jay Smith1, Gerald R. Cooper1 and Eric J. Sampson1

1 Centers for Disease Control and Prevention, 4770 Buford Hwy NE (F25), Atlanta, GA 30341.
a Author for correspondence. Fax 770-488-4192; e-mail glm1{at}cdc.gov

Background: Accurate and precise measurement of blood cholesterol plays a central role in the National Cholesterol Education Program’s strategy to reduce the morbidity and mortality attributable to coronary heart disease. Matrix effects hamper the ability of manufacturers to adequately calibrate and validate traceability to the National Reference System for Cholesterol (NRS/CHOL). CDC created the Cholesterol Reference Method Laboratory Network (CRMLN) to improve cholesterol measurement by assisting manufacturers of in vitro diagnostic products with validation of the traceability of their assays to the NRS/CHOL.

Methods: CRMLN laboratories established the CDC cholesterol reference method (modification of the Abell-Levy-Brodie-Kendall chemical method) and are standardized using CDC frozen serum reference materials. CRMLN laboratories use common quality-control materials and participate in monthly external performance evaluations conducted by CDC. The CRMLN performance criteria require member laboratories to agree with CDC within ± 1.0% and maintain a CV <=2.0%.

Results: From 1995 to 2000, the CRMLN laboratories met the accuracy criterion 97% of the time and the precision criterion 99% of the time. During this time period, the CRMLN maintained an average bias to CDC of 0.01% and an average collective CV of 0.33%.

Conclusions: CDC established the CRMLN as the first international reference method laboratory network. The CRMLN assists manufacturers in the validation of the calibration of their diagnostic products so that clinical laboratories can measure blood cholesterol more reliably. The CRMLN can serve as a model for other clinical analytes where traceability to a hierarchy of methods is needed and matrix effects of the field methods with processed calibrators or reference materials are present.




The following articles in journals at HighWire Press have cited this article:


Home page
 Am. J. Clin. Nutr.Home page
C. Corvalan, R. Uauy, A. D Stein, J. Kain, and R. Martorell
Effect of growth on cardiometabolic status at 4 y of age
Am. J. Clinical Nutrition, September 1, 2009; 90(3): 547 - 555.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Branford, L. Fletcher, N. C. P. Cross, M. C. Muller, A. Hochhaus, D.-W. Kim, J. P. Radich, G. Saglio, F. Pane, S. Kamel-Reid, et al.
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials
Blood, October 15, 2008; 112(8): 3330 - 3338.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
Y. Nakamura, H. Ueshima, N. Okuda, A. Higashiyama, Y. Kita, T. Kadowaki, T. Okamura, Y. Murakami, A. Okayama, S. R. Choudhury, et al.
Relation of dietary and other lifestyle traits to difference in serum adiponectin concentration of Japanese in Japan and Hawaii: the INTERLIPID Study
Am. J. Clinical Nutrition, August 1, 2008; 88(2): 424 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Ann Clin BiochemHome page
R. Cramb, J. French, M. Mackness, R D. G Neely, M. Caslake, and F. MacKenzie
Lipid external quality assessment: commutability between external quality assessment and clinical specimens
Ann Clin Biochem, May 1, 2008; 45(3): 260 - 265.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. J. Packard, I. Ford, M. Robertson, J. Shepherd, G. J. Blauw, M. B. Murphy, E. L.E.M. Bollen, B. M. Buckley, S. M. Cobbe, A. Gaw, et al.
Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
Circulation, November 15, 2005; 112(20): 3058 - 3065.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
E. K. Kabagambe, J. Furtado, A. Baylin, and H. Campos
Some Dietary and Adipose Tissue Carotenoids Are Associated with the Risk of Nonfatal Acute Myocardial Infarction in Costa Rica
J. Nutr., July 1, 2005; 135(7): 1763 - 1769.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
E. K. Kabagambe, A. Baylin, E. Ruiz-Narvarez, X. Siles, and H. Campos
Decreased Consumption of Dried Mature Beans Is Positively Associated with Urbanization and Nonfatal Acute Myocardial Infarction
J. Nutr., July 1, 2005; 135(7): 1770 - 1775.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. M. Thienpont, K. Van Uytfanghe, J. Marriot, P. Stokes, L. Siekmann, A. Kessler, D. Bunk, and S. Tai
Metrologic Traceability of Total Thyroxine Measurements in Human Serum: Efforts to Establish a Network of Reference Measurement Laboratories
Clin. Chem., January 1, 2005; 51(1): 161 - 168.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. Rifai, G. R. Cooper, W. V. Brown, W. Friedewald, R. J. Havel, G. L. Myers, and G. R. Warnick
Clinical Chemistry Journal Has Contributed to Progress in Lipid and Lipoprotein Testing for Fifty Years
Clin. Chem., October 1, 2004; 50(10): 1861 - 1870.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
Y. Nakamura, T. Okamura, S. Tamaki, T. Kadowaki, T. Hayakawa, Y. Kita, A. Okayama, and H. Ueshima
Egg consumption, serum cholesterol, and cause-specific and all-cause mortality: the National Integrated Project for Prospective Observation of Non-communicable Disease and Its Trends in the Aged, 1980 (NIPPON DATA80)
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 58 - 63.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
C. Gillespie, C. Ballew, B. A Bowman, R. Donehoo, and M. K Serdula
Intraindividual variation in serum retinol concentrations among participants in the third National Health and Nutrition Examination Survey, 1988-1994
Am. J. Clinical Nutrition, April 1, 2004; 79(4): 625 - 632.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
H. M. Blanck, B. A. Bowman, G. R. Cooper, G. L. Myers, and D. T. Miller
Laboratory Issues: Use of Nutritional Biomarkers
J. Nutr., March 1, 2003; 133(3): 888S - 894.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Baadenhuijsen, H. Steigstra, C. Cobbaert, A. Kuypers, C. Weykamp, and R. Jansen
Commutability Assessment of Potential Reference Materials Using a Multicenter Split-Patient-Sample Between-Field-Methods (Twin-Study) Design: Study within the Framework of the Dutch Project "Calibration 2000"
Clin. Chem., September 1, 2002; 48(9): 1520 - 1525.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Cobbaert, C. Weykamp, H. Baadenhuijsen, A. Kuypers, J. Lindemans, and R. Jansen
Selection, Preparation, and Characterization of Commutable Frozen Human Serum Pools as Potential Secondary Reference Materials for Lipid and Apolipoprotein Measurements: Study within the Framework of the Dutch Project "Calibration 2000"
Clin. Chem., September 1, 2002; 48(9): 1526 - 1538.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Nauck, G. R. Warnick, and N. Rifai
Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation
Clin. Chem., February 1, 2002; 48(2): 236 - 254.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. R. Warnick, G. L. Myers, G. R. Cooper, and N. Rifai
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory
Clin. Chem., January 1, 2002; 48(1): 11 - 17.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
E. K. Kabagambe, A. Baylin, D. A. Allan, X. Siles, D. Spiegelman, and H. Campos
Application of the Method of Triads to Evaluate the Performance of Food Frequency Questionnaires and Biomarkers as Indicators of Long-term Dietary Intake
Am. J. Epidemiol., December 15, 2001; 154(12): 1126 - 1135.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. R. Little, C. L. Rohlfing, H.-M. Wiedmeyer, G. L. Myers, D. B. Sacks, and D. E. Goldstein
The National Glycohemoglobin Standardization Program: A Five-Year Progress Report
Clin. Chem., November 1, 2001; 47(11): 1985 - 1992.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. R. Warnick, M. Nauck, and N. Rifai
Evolution of Methods for Measurement of HDL-Cholesterol: From Ultracentrifugation to Homogeneous Assays
Clin. Chem., September 1, 2001; 47(9): 1579 - 1596.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. M. Kisabeth
Laboratory Adaptations--Changing Expectations
Clin. Chem., August 1, 2001; 47(8): 1509 - 1515.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
U.-H. Stenman
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?
Clin. Chem., May 1, 2001; 47(5): 815 - 820.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.